33 results
424B5
CGTX
Cognition Therapeutics Inc
13 Mar 24
Prospectus supplement for primary offering
4:04pm
of operations, business strategy, and financial needs. In light of the significant uncertainties in these forward-looking statements, you should not rely upon … , and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy
424B5
CGTX
Cognition Therapeutics Inc
11 Mar 24
Prospectus supplement for primary offering
4:06pm
, and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy … and financial trends that we believe may affect our financial condition, results of operations, business strategy, and financial needs. In light
424B4
w32tpqwqih1a
8 Jan 24
Prospectus supplement with pricing info
4:11pm
8-K
EX-99.1
qm78zq14hzjl565plmfm
12 Sep 23
Other Events
7:00am
8-K
EX-99.1
a0xh72fz6od4nmtra
24 Aug 23
Regulation FD Disclosure
7:00am
8-K
EX-99.1
k91fy vh6wqk8k
4 May 23
Cognition Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
4:06pm
S-3
td22 ilsal83
23 Dec 22
Shelf registration
4:16pm
424B4
xmgaegj52k 527
14 Nov 22
Prospectus supplement with pricing info
6:02am
DRS
462elu0 3kh016
20 Oct 22
Draft registration statement
12:00am